Vietnamese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Nanshan Elderly Cohort Study

Chỉ người dùng đã đăng ký mới có thể dịch các bài báo
Đăng nhập Đăng ký
Liên kết được lưu vào khay nhớ tạm
Trạng tháiTuyển dụng
Các nhà tài trợ
Sun Yat-sen University
Cộng tác viên
Shenzhen Nanshan Center for Chronic Disease Control

Từ khóa

trừu tượng

Objective: The Nanshan Elderly Cohort Study (NECS) aims to investigate the nutritional, as well as other environmental and genetic factors of chronic diseases, such as cardio-metabolic diseases.
Study design: NECS is a community-based prospective cohort study. Participants: About 10000-20000 apparently healthy residents, living in Nanshan, Shenzhen (South China) for >5 years, aged ≥ 65 years, will be recruited between 2018 and 2019.
Visits and Data Collection: Participants will be followed up approximately every 3 years by invited to the Community Healthcare Service Centre. At each survey, face-to-face interviews, anthropometric measurements, ultrasonography examination, electrocardiogram test and specimen collection will be conducted.
Key variables:
1. Face-to-face interviews: Structured questionnaires will be used to collect the participants' socio-demographic characteristics, lifestyles, habitual dietary intake, physical activity, history of chronic diseases, use of supplements and medications, family history, psychological health and cognitive function.
2. Physical examinations: Anthropometric measurements, blood pressure tests, handgrip strength, and usual gait speed.
3. Ultrasonography examinations: Ultrasonography examination will be performed to determine carotid artery intima-media thickness and plaque, fatty liver.
4. Electrocardiogram test: Electrocardiogram test is to obtain information about the structure and function of the heart.
5. Specimen collections: Overnight fasting blood sample, early morning first-void urine sample and faeces samples will be collected and stored at −80°C till tests.
6. Laboratory tests:
1. Blood tests: Metabolic syndrome-related indices; nutritional indices; inflammatory markers; sexual hormones; genetic markers.
2. Urinary tests: Flavonoids and flavones, minerals, creatinine and renal function related markers.
3. Fecal test: Gut microbiota and related metabolites.
7. Morbidity and mortality: Relevant data will be also retrieved via local multiple Health information systems.
8. Others: Many other laboratory tests or instrument tests will be developed depended on needs and resources in future.

Sự miêu tả

Objective: The Nanshan Elderly Cohort Study (NECS) aims to investigate the nutritional, as well as other environmental and genetic factors of chronic diseases, such as hypertension, type 2 diabetes mellitus, cardiovascular diseases, stroke, obesity, metabolic syndrome, chronic kidney disease, cancer and sarcopenia.

Study design: NECS is a community-based prospective cohort study. Participants: Healthy residents who had lived in Nanshan, Shenzhen (South China) for >5 years, aged ≥ 65 years are eligible. Participants would be excluded if they are confirmed to have serious chronic diseases, such as cardiovascular disease, liver or renal failure, or cancer. About 10000-20000 apparently healthy residents will be recruited between 2018 and 2019.

Visits and Data Collection: Participants will be followed up approximately every 3 years by invited to the Community Healthcare Service Centre. At each survey, face-to-face interviews, anthropometric measurements, ultrasonography examinations, electrocardiogram test and specimen collection will be conducted.

Key variables:

1. Face-to-face interviews: Structured questionnaires will be used to collect the participants' socio-demographic characteristics (e.g., age, sex and household income, education level), lifestyles (smoking, passive smoking, alcohol and tea drinking), habitual dietary intake (a 62-item quantitative food frequency questionnaire), physical activity, history of chronic diseases, use of supplements and medications, family history, psychological health (Self-Rating Anxiety Scale, SAS), social support and participation, cognitive function (Mini-Mental State Examinations, MMSE);

2. Physical examinations: Anthropometric measurements (weight, height, waist, hip and neck circumference, etc.), blood pressure tests, handgrip strength, and usual gait speed.

3. Ultrasonography examinations: Ultrasonography examination of the carotid artery and upper abdominal organs (e.g., liver and kidney) will be performed to determine carotid artery intima-media thickness and plaque, fatty liver.

4. Electrocardiogram test: Electrocardiogram test is to obtain information about the structure and function of the heart.

5. Specimen collections: Overnight fasting blood sample will be collected and separated into serum, plasma, red blood cell and leukocyte within two hours. Early morning first-void urine sample and faeces samples will be collected. All specimens will separated and stored at −80°C till tests.

6. Laboratory tests:

1. Metabolic syndrome-related indices: Fasting serum lipid profile (e.g., cholesterol, triglycerides, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol), diabetes-related indices (e.g., glucose, glycated hemoglobin, fructosamine and insulin), uric acid and creatinine;

2. Nutritional indices: Serum concentrations of carotenoids, erythrocyte fatty acids, serum minerals, folate, betaine, choline, TMAO, and vitamin D, etc.

3. Inflammatory markers (e.g., hsCRP, RBP4,IL-6, TNF-a)

4. Sexual hormones (e.g., testosterone, SHBG)

5. Genetic markers

6. Urinary tests: Flavonoids and flavones, minerals, creatinine and renal function related markers.

7. Fecal test: Gut microbiota and related metabolites.

7. Morbidity and mortality: Relevant data will be also retrieved via local multiple Health information systems.

8. Others: Many other laboratory tests or instrument tests will be developed depended on needs and resources in future.

Statistical analysis: Cox proportional hazards models or logistic regression models will be used to estimate the risk of exposures on categorical outcomes. Path analysis also will be used to assess the potential mediating effects in the causal pathway between exposures and outcomes.

ngày

Xác minh lần cuối: 05/31/2018
Đệ trình đầu tiên: 05/21/2018
Đăng ký ước tính đã được gửi: 06/22/2018
Đăng lần đầu: 06/25/2018
Cập nhật lần cuối được gửi: 06/22/2018
Cập nhật lần cuối đã đăng: 06/25/2018
Ngày bắt đầu nghiên cứu thực tế: 05/25/2018
Ngày hoàn thành chính ước tính: 12/29/2028
Ngày hoàn thành nghiên cứu ước tính: 12/29/2028

Tình trạng hoặc bệnh tật

Hypertension
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Stroke
Obesity
Metabolic Syndrome
Sarcopenia
Chronic Kidney Disease
Cancer
Death

Giai đoạn

-

Đủ tiêu chuẩn

Tuổi đủ điều kiện để học 65 Years Đến 65 Years
Giới tính đủ điều kiện để nghiên cứuAll
Phương pháp lấy mẫuNon-Probability Sample
Chấp nhận tình nguyện viên lành mạnhĐúng
Tiêu chí

Inclusion Criteria:

- Age: ≥ 65 years;

- Living in Nanshan, Shenzhen for at least 5 years;

- Chinese.

Exclusion Criteria:

- Had a history of hospital-confirmed diabetes, failure(s) of heart, liver, or kidney, cancer, CVD events;

- On special diet due to a disease or weight control;

- Mental and physical disability;

- Likely to move to other city within 5 years;

- Did not want to attend any one item of the survey or sample collection.

Kết quả

Các biện pháp kết quả chính

1. Diabetes mellitus [Up to 10 years]

The investigators will also track for occurrence of diabetes mellitus by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention and Health Insurance Bureau. All cases will be verified by medical record reviews.

2. Cardiovascular diseases (occurrence of cardiovascular diseases) [Up to 10 years]

The investigators will track for occurrence of cardiovascular diseases by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.

3. Stroke (occurrence of stroke) [Up to 10 years]

The investigators will track for occurrence of stroke by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.

4. Cognitive disorder (occurrence of cognitive disorder) [Up to 10 years]

The investigators will track for occurrence of cognitive disorder by follow-up surveys and annual record linkage to the population-based disease or death registry collected by the Shenzhen Center for Disease Control and Prevention, and Health Insurance Bureau. All cases will be verified by medical record reviews.

Các biện pháp kết quả thứ cấp

1. Metabolic syndrome [Up to 10 years]

The investigators will measure metabolic syndrome-related indices at each visit (per every 3 years), the investigators can analysis the incidence of metabolic syndrome.

2. Change lipid profile [Up to 10 years]

The investigators will measure fasting lipid profile (e.g., cholesterol, triglycerides, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol) at each visit, and analyse the change of these indices.

3. Handgrip strength [Up to 10 years]

The investigators will measure the handgrip strength, which will be used to diagnose sarcopenia according to definition recommended by Asian Working Group for Sarcopenia (AWGS): cutoff values for handgrip strength (<26 kg for men and <18 kg for women).

4. Usual gait speed [Up to 10 years]

The investigators will measure the usual gait speed., which will also be used to diagnose sarcopenia according to definition recommended by Asian Working Group for Sarcopenia (AWGS): cutoff values for usual gait speed (<0.8 m/s).

Tham gia trang
facebook của chúng tôi

Cơ sở dữ liệu đầy đủ nhất về dược liệu được hỗ trợ bởi khoa học

  • Hoạt động bằng 55 ngôn ngữ
  • Phương pháp chữa bệnh bằng thảo dược được hỗ trợ bởi khoa học
  • Nhận dạng các loại thảo mộc bằng hình ảnh
  • Bản đồ GPS tương tác - gắn thẻ các loại thảo mộc vào vị trí (sắp ra mắt)
  • Đọc các ấn phẩm khoa học liên quan đến tìm kiếm của bạn
  • Tìm kiếm dược liệu theo tác dụng của chúng
  • Sắp xếp sở thích của bạn và cập nhật các nghiên cứu tin tức, thử nghiệm lâm sàng và bằng sáng chế

Nhập một triệu chứng hoặc một căn bệnh và đọc về các loại thảo mộc có thể hữu ích, nhập một loại thảo mộc và xem các bệnh và triệu chứng mà nó được sử dụng để chống lại.
* Tất cả thông tin dựa trên nghiên cứu khoa học đã được công bố

Google Play badgeApp Store badge